NCRI
National Cancer Research Institute
Ongoing Trials:
- mEOC-study : a multicentre randomized GCIG Intergroup trial comparing oxaliplatin + capecitabine versus carboplatin + paclitaxel in patients with previously untreated mucinous ovarian cancer.
- ICON-6 : phase I-, phase III study of cediranib versus control in combination with and maintenance therapy after platin-based chemotherapy.
• Back